Developer docs
API playgroundTry for free, no card

Search company profiles

BlinkRx

Full company profile

uuid00004et

Namestring
BlinkRx
Legal namestring
Blink Health Administration LLC
Company typeenum
Private
Founded yearint
2014
Descriptiontext

BlinkRx (legal entity: Blink Health Administration LLC) is a New York-based digital health company founded in 2014 that operates a prescription lifecycle management platform connecting patients to branded and generic medications with transparent pricing and home delivery. The company serves two distinct customer bases: (1) Life Sciences and pharmaceutical manufacturers, who use BlinkRx to design and operate direct-to-consumer drug channels for branded medications through its core platform, and (2) cash-pay consumers, who access lower-cost generics through the Quick Save discount program at thousands of participating pharmacies and the Cash Express mail-order service.

The platform is built around three product lines. BlinkRx is the flagship B2B Prescription Lifecycle Management Platform that allows Life Sciences companies to control the prescription journey end-to-end. Quick Save is a freemium, cash-pay pharmacy discount solution that claims lower prices than legacy coupon programs (e.g., Phentermine at $7.93 vs. $8.12 coupon, Lipitor at $7.96 vs. $9.09 coupon, Zocor at $3.40 vs. $4.00 coupon). Blink Cash Express is a mail-order generic fulfillment service with home delivery. Distribution runs through BlinkRx's own iOS/Android apps and web platform, a participating pharmacy network of thousands of U.S. locations, the Cash Express mail-order infrastructure, and an integration with the federal TrumpRx.gov portal that funnels DTC drug sales from manufacturers including Eli Lilly and Pfizer.

Revenue is generated through a mix of recurring manufacturer partnership fees, transaction-based economics on Quick Save discount usage at participating pharmacies, and transaction fees on Cash Express mail-order fulfillment and product collaborations such as the Scienture Holdings Arbli distribution deal. The company is venture-backed, having raised approximately $315 million across disclosed rounds since 2014, with a $140 million Series 3 led by 1789 Capital in November 2024 as the most recent and largest funding event. Headcount stands at 600+ employees, including 200+ in technology, with offices in New York City, Pittsburgh, St. Louis, and Boise. Notable governance and advisory relationships include Donald Trump Jr. on the board (subject to a February 2026 Senate investigation) and former Senator Joe Manchin and former Mylan CEO Heather Manchin as Senior Advisors through Manchin Partners.

Short descriptiontext

BlinkRx is a digital health company that operates a prescription lifecycle management platform for pharmaceutical manufacturers alongside consumer-facing cash-pay pharmacy discount (Quick Save) and mail-order generic (Cash Express) services in the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription access platform, digital pharmacy services, pharmacy benefit management, prescription lifecycle management, cash pay medications
Industry2 codes
1Medication Adherence, Reminders & Patient Support
CodeHLACAKAFPrimaryYes
2Virtual Pharmacy & Medication Management Integration Platforms
CodeHLALABALPrimaryNo
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Pharmacies and Drug Retailers45611
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Digital Pharmacy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Manufacturer Partnerships
TypeSubscription Recurring
Description

BlinkRx helps drugmakers establish direct-to-consumer channels and manages prescription journeys for branded medications, generating revenue through partnerships with pharmaceutical companies seeking to expand patient access

drugdiscoverytrends.com
2Quick Save Discount Program
TypeTransaction Fee
Description

Cash-pay prescription discount program offering lower prices than legacy coupon solutions at participating pharmacies, with revenue generated through pharmacy network partnerships

blinkhealth.com
3Product Collaboration
TypeTransaction Fee
Description

Strategic collaboration to expand access to FDA-approved medications through the platform, including products like Arbli (losartan oral suspension)

biospace.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Quick Save - Free cash-pay discount program
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free to use with no membership fees. Offers lower prices than legacy coupon solutions at thousands of participating pharmacies.

blinkhealth.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1BlinkRx
Description

Prescription Lifecycle Management Platform that allows Life Sciences companies to design every aspect of the prescription journey to unlock branded medication affordability and access.

blinkhealth.com
+2 more records
Core offering1 text field

BlinkRx operates a Prescription Lifecycle Management Platform that connects pharmaceutical manufacturers, pharmacies, and patients to improve access to medications. The company offers cash-pay discount programs for generic drugs through a national network of participating pharmacies and a home-delivery mail-order service, while providing branded medication access services and platform capabilities directly to life sciences companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Lower prices than legacy coupon solutions on cash-pay medications
Product overview1 text field

BlinkRx operates as a digital health platform with three integrated offerings: BlinkRx is the core Prescription Lifecycle Management Platform for branded medications targeting Life Sciences companies; Blink Quick Save is a discount solution for generic medications offering lower cash-pay prices at participating pharmacies; and Blink Cash Express is a mail order service for generic medications with home delivery. Together, these products address different segments of the prescription medication access and affordability market.

Product and service3 records
1BlinkRx
CategoryPrescription Lifecycle Management
Description

Prescription Lifecycle Management Platform designed for life sciences companies that provides patients with direct access to branded medications through Blink Health Administration. Serves pharmaceutical manufacturers and their branded drug portfolios.

2Blink Quick Save
CategoryCash-Pay Pharmacy Discount
Description

Free, no-commitment cash-pay discount program that provides patients with discounted pricing on generic medications filled at thousands of participating pharmacies nationwide. Targeted at patients paying cash for prescription medications.

3Blink Cash Express
CategoryMail-Order Pharmacy
Description

Mail-order service offering generic medications with home delivery, designed for patients seeking convenience and cash-pay pricing for ongoing prescription needs.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-06
Description

BlinkRx appointed former U.S. Senator Joe Manchin and healthcare executive Heather Manchin as Senior Advisors through their strategic advisory firm Manchin Partners. Senator Manchin brings bipartisan policy experience while Heather Manchin adds operational expertise from her tenure as former CEO of pharmaceutical company Mylan. The advisors will provide strategic counsel to BlinkRx's leadership as the company works to expand its prescription journey management platform and reduce medication costs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

Strategic collaboration to expand patient access to Arbli, the first FDA-approved ready-to-use oral suspension of losartan potassium. The product is expected to be accessible through BlinkRx's platform in Q1 2026, aiming to meet the needs of patients requiring alternative dosage forms.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

BlinkRx helps drugmakers establish direct-to-consumer channels that are now funneled through the federal TrumpRx.gov portal. The platform enables pharmaceutical manufacturers to sell medications at discounts through a federal DTC platform launched in January.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GoodRx is the dominant prescription discount platform in the U.S., offering free coupons and a subscription service (GoodRx Gold) for cash-pay medications. It is the most direct competitor to Blink Quick Save and shares BlinkRx's core mission of making medications more affordable for cash-pay patients.

TypeDirect peer
Description

SingleCare is a prescription savings card and discount program that negotiates lower prices at participating pharmacies. It competes head-to-head with Blink Quick Save in the cash-pay prescription discount market with a similar freemium model and pharmacy network approach.

TypeDirect peer
Description

RxSaver (owned by RetailMeNot) provides a free prescription discount card accepted at major U.S. pharmacies. It is a direct competitor to Blink Quick Save, focused on the same cash-pay consumer segment and offering similar price comparison functionality.

TypeDirect peer
Description

Cost Plus Drugs is a direct-to-consumer online pharmacy that sells generic medications at transparent, cost-plus pricing with home delivery. It competes directly with Blink Cash Express in the mail-order generic medication space and shares the same mission of disrupting legacy pharmacy pricing.

TypeDirect peer
Description

Alto is a digital pharmacy offering same-day medication delivery and adherence tools, with a focus on chronic condition management. It competes with Blink Cash Express on mail-order delivery and overlaps with BlinkRx's prescription management technology for chronic patients.

TypeDirect peer
Description

Capsule is a digital-first pharmacy offering same-day free delivery, prescription management, and coordinated provider communication. It competes with Blink Cash Express on mail-order delivery and is comparable in scale and digital-first approach.

TypeBroad incumbent
Description

Amazon Pharmacy is a broad online prescription service integrated into Amazon's ecosystem, offering discount pricing, free delivery for Prime members, and PillPack-style adherence packaging. It competes with both Quick Save and Cash Express, leveraging Amazon's massive consumer base and logistics infrastructure.

8LillyDirect
TypeEmerging player
Description

Eli Lilly's direct-to-consumer platform for Lilly medications, including obesity drug Zepbound, is a direct comparison to the BlinkRx prescription lifecycle management platform for branded drugs. As a pharma-owned DTC channel, it represents both a customer/partner for BlinkRx and a potential competitive threat.

TypeBroad incumbent
Description

Walgreens operates a major retail pharmacy network with a digital prescription management and discount platform. As a participating pharmacy in BlinkRx's Quick Save network, it is a partner, but its scale, owned digital channels, and integrated services make it a broad incumbent in the same space.

TypeBroad incumbent
Description

CVS Caremark is one of the largest PBMs and pharmacy benefit managers in the U.S., managing prescription drug benefits for health plans and employers. As a competitor in the broader prescription access ecosystem, it competes with BlinkRx on drug pricing transparency and could be both a partner (participating pharmacy) and a competitive threat through its own DTC initiatives.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BlinkRx

Digital Pharmacy Servicesblinkhealth.com

BlinkRx is a digital health company that operates a prescription lifecycle management platform for pharmaceutical manufacturers alongside consumer-facing cash-pay pharmacy discount (Quick Save) and mail-order generic (Cash Express) services in the United States.

What BlinkRx does

BlinkRx (legal entity: Blink Health Administration LLC) is a New York-based digital health company founded in 2014 that operates a prescription lifecycle management platform connecting patients to branded and generic medications with transparent pricing and home delivery. The company serves two distinct customer bases: (1) Life Sciences and pharmaceutical manufacturers, who use BlinkRx to design and operate direct-to-consumer drug channels for branded medications through its core platform, and (2) cash-pay consumers, who access lower-cost generics through the Quick Save discount program at thousands of participating pharmacies and the Cash Express mail-order service.

The platform is built around three product lines. BlinkRx is the flagship B2B Prescription Lifecycle Management Platform that allows Life Sciences companies to control the prescription journey end-to-end. Quick Save is a freemium, cash-pay pharmacy discount solution that claims lower prices than legacy coupon programs (e.g., Phentermine at $7.93 vs. $8.12 coupon, Lipitor at $7.96 vs. $9.09 coupon, Zocor at $3.40 vs. $4.00 coupon). Blink Cash Express is a mail-order generic fulfillment service with home delivery. Distribution runs through BlinkRx's own iOS/Android apps and web platform, a participating pharmacy network of thousands of U.S. locations, the Cash Express mail-order infrastructure, and an integration with the federal TrumpRx.gov portal that funnels DTC drug sales from manufacturers including Eli Lilly and Pfizer.

Revenue is generated through a mix of recurring manufacturer partnership fees, transaction-based economics on Quick Save discount usage at participating pharmacies, and transaction fees on Cash Express mail-order fulfillment and product collaborations such as the Scienture Holdings Arbli distribution deal. The company is venture-backed, having raised approximately $315 million across disclosed rounds since 2014, with a $140 million Series 3 led by 1789 Capital in November 2024 as the most recent and largest funding event. Headcount stands at 600+ employees, including 200+ in technology, with offices in New York City, Pittsburgh, St. Louis, and Boise. Notable governance and advisory relationships include Donald Trump Jr. on the board (subject to a February 2026 Senate investigation) and former Senator Joe Manchin and former Mylan CEO Heather Manchin as Senior Advisors through Manchin Partners.

BlinkRx firmographics

Firmographics
Name
BlinkRx
Legal name
Blink Health Administration LLC
Website
https://blinkhealth.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
501–1,000 employees
Short description
BlinkRx is a digital health company that operates a prescription lifecycle management platform for pharmaceutical manufacturers alongside consumer-facing cash-pay pharmacy discount (Quick Save) and mail-order generic (Cash Express) services in the United States.
Ownership category
akta.pro rank

BlinkRx industry classification

Industry
Product category
Digital Pharmacy Services
NAICS
Pharmacies and Drug Retailers (456110), Pharmacies and Drug Retailers (45611)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
Medication Adherence, Reminders & Patient Support (HLACAKAF)
akta.pro secondary industry
Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

  • Prescription access platform
  • Digital pharmacy services
  • Pharmacy benefit management
  • Prescription lifecycle management
  • Cash pay medications

Where BlinkRx is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices4 records

Markets served

BlinkRx business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical Manufacturer Partnerships: BlinkRx helps drugmakers establish direct-to-consumer channels and manages prescription journeys for branded medications, generating revenue through partnerships with pharmaceutical companies seeking to expand patient access
  2. Quick Save Discount Program: Cash-pay prescription discount program offering lower prices than legacy coupon solutions at participating pharmacies, with revenue generated through pharmacy network partnerships
  3. Product Collaboration: Strategic collaboration to expand access to FDA-approved medications through the platform, including products like Arbli (losartan oral suspension)

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goQuick Save - Free cash-pay discount program

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

BlinkRx product offering

Product offering

Core offering

BlinkRx operates a Prescription Lifecycle Management Platform that connects pharmaceutical manufacturers, pharmacies, and patients to improve access to medications. The company offers cash-pay discount programs for generic drugs through a national network of participating pharmacies and a home-delivery mail-order service, while providing branded medication access services and platform capabilities directly to life sciences companies.

Product overview

BlinkRx operates as a digital health platform with three integrated offerings: BlinkRx is the core Prescription Lifecycle Management Platform for branded medications targeting Life Sciences companies; Blink Quick Save is a discount solution for generic medications offering lower cash-pay prices at participating pharmacies; and Blink Cash Express is a mail order service for generic medications with home delivery. Together, these products address different segments of the prescription medication access and affordability market.

Differentiator

Problem solved

Functional benefit

Brands

  • BlinkRx: Prescription Lifecycle Management Platform that allows Life Sciences companies to design every aspect of the prescription journey to unlock branded medication affordability and access.
  • Quick Save
  • Blink Cash Express

Products and services

  • BlinkRx Prescription Lifecycle Management Platform designed for life sciences companies that provides patients with direct access to branded medications through Blink Health Administration. Serves pharmaceutical manufacturers and their branded drug portfolios.
  • Blink Quick Save Free, no-commitment cash-pay discount program that provides patients with discounted pricing on generic medications filled at thousands of participating pharmacies nationwide. Targeted at patients paying cash for prescription medications.
  • Blink Cash Express Mail-order service offering generic medications with home delivery, designed for patients seeking convenience and cash-pay pricing for ongoing prescription needs.

Quantifiable outcome

  • Lower prices than legacy coupon solutions on cash-pay medications

Companies that use BlinkRx

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

BlinkRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

BlinkRx partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • Manchin Partners (Sen. Joe Manchin and Heather Manchin)coreStrategic or Co-development Partner · 6 February 2026BlinkRx appointed former U.S. Senator Joe Manchin and healthcare executive Heather Manchin as Senior Advisors through their strategic advisory firm Manchin Partners. Senator Manchin brings bipartisan policy experience while Heather Manchin adds operational expertise from her tenure as former CEO of pharmaceutical company Mylan. The advisors will provide strategic counsel to BlinkRx's leadership as the company works to expand its prescription journey management platform and reduce medication costs.
  • Scienture HoldingscoreStrategic or Co-development Partner · 10 December 2025Strategic collaboration to expand patient access to Arbli, the first FDA-approved ready-to-use oral suspension of losartan potassium. The product is expected to be accessible through BlinkRx's platform in Q1 2026, aiming to meet the needs of patients requiring alternative dosage forms.
  • TrumpRx/Federal GovernmentflagshipChannel Partner/ Reseller/ DistributorBlinkRx helps drugmakers establish direct-to-consumer channels that are now funneled through the federal TrumpRx.gov portal. The platform enables pharmaceutical manufacturers to sell medications at discounts through a federal DTC platform launched in January.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

BlinkRx competitors and assessment

Company assessment

Direct peers

  • GoodRx: GoodRx is the dominant prescription discount platform in the U.S., offering free coupons and a subscription service (GoodRx Gold) for cash-pay medications. It is the most direct competitor to Blink Quick Save and shares BlinkRx's core mission of making medications more affordable for cash-pay patients.
  • SingleCare: SingleCare is a prescription savings card and discount program that negotiates lower prices at participating pharmacies. It competes head-to-head with Blink Quick Save in the cash-pay prescription discount market with a similar freemium model and pharmacy network approach.
  • RxSaver: RxSaver (owned by RetailMeNot) provides a free prescription discount card accepted at major U.S. pharmacies. It is a direct competitor to Blink Quick Save, focused on the same cash-pay consumer segment and offering similar price comparison functionality.
  • Mark Cuban Cost Plus Drugs: Cost Plus Drugs is a direct-to-consumer online pharmacy that sells generic medications at transparent, cost-plus pricing with home delivery. It competes directly with Blink Cash Express in the mail-order generic medication space and shares the same mission of disrupting legacy pharmacy pricing.
  • Alto Pharmacy: Alto is a digital pharmacy offering same-day medication delivery and adherence tools, with a focus on chronic condition management. It competes with Blink Cash Express on mail-order delivery and overlaps with BlinkRx's prescription management technology for chronic patients.
  • Capsule Pharmacy: Capsule is a digital-first pharmacy offering same-day free delivery, prescription management, and coordinated provider communication. It competes with Blink Cash Express on mail-order delivery and is comparable in scale and digital-first approach.

Broad incumbents

  • Amazon Pharmacy: Amazon Pharmacy is a broad online prescription service integrated into Amazon's ecosystem, offering discount pricing, free delivery for Prime members, and PillPack-style adherence packaging. It competes with both Quick Save and Cash Express, leveraging Amazon's massive consumer base and logistics infrastructure.
  • Walgreens Find Care: Walgreens operates a major retail pharmacy network with a digital prescription management and discount platform. As a participating pharmacy in BlinkRx's Quick Save network, it is a partner, but its scale, owned digital channels, and integrated services make it a broad incumbent in the same space.
  • CVS Caremark: CVS Caremark is one of the largest PBMs and pharmacy benefit managers in the U.S., managing prescription drug benefits for health plans and employers. As a competitor in the broader prescription access ecosystem, it competes with BlinkRx on drug pricing transparency and could be both a partner (participating pharmacy) and a competitive threat through its own DTC initiatives.

Emerging players

  • LillyDirect: Eli Lilly's direct-to-consumer platform for Lilly medications, including obesity drug Zepbound, is a direct comparison to the BlinkRx prescription lifecycle management platform for branded drugs. As a pharma-owned DTC channel, it represents both a customer/partner for BlinkRx and a potential competitive threat.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BlinkRx social profiles

Digital presence

BlinkRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BlinkRx leadership team

Management profile

Number of profiles

Profiles6 records

BlinkRx funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BlinkRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlinkRx

What does BlinkRx do?

BlinkRx operates a Prescription Lifecycle Management Platform that connects pharmaceutical manufacturers, pharmacies, and patients to improve access to medications. The company offers cash-pay discount programs for generic drugs through a national network of participating pharmacies and a home-delivery mail-order service, while providing branded medication access services and platform capabilities directly to life sciences companies.

Is BlinkRx a public or private company?

BlinkRx is a private company. It is classified as venture growth investor backed and is currently operating.

When was BlinkRx founded?

BlinkRx was founded in 2014. It employs 501 to 1,000 people.

Where is BlinkRx based?

BlinkRx is headquartered in New York, United States, in the North America region.

How does BlinkRx make money?

Three revenue lines are on record. Pharmaceutical Manufacturer Partnerships are the primary driver. The others are quick Save Discount Program and product Collaboration.

Who are BlinkRx's main competitors?

Direct peers on record are GoodRx, SingleCare, RxSaver, Mark Cuban Cost Plus Drugs, Alto Pharmacy and Capsule Pharmacy. Broad incumbents are Amazon Pharmacy, Walgreens Find Care and CVS Caremark. LillyDirect is listed as an emerging player.

Does BlinkRx have an API?

No public API is recorded for BlinkRx.

What industry is BlinkRx in?

BlinkRx's product category is Digital Pharmacy Services. Its primary akta.pro industry code is HLACAKAF, Medication Adherence, Reminders & Patient Support, with a secondary code of HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms. Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comPhathom at Cantor conference: growth, access and new uses By Investing.comPhathom Pharmaceuticals presented at the Cantor conference, reporting first quarterly operating profit and raising full-year revenue guidance to $310–325 million. The company cited 97% physician support for VOQUEZNA and a BlinkRx partnership to ease access, with potential peak revenue exceeding $2 billion.PR NewswireORASIS PHARMACEUTICALS DOUBLES DOWN ON EYE CARE PROFESSIONALS, NOT TELEHEALTH, AS QLOSI® REFILLS REACH 49%¹Orasis Pharmaceuticals announced two new access options for Qlosi, a presbyopia eye drop, including a First Fill Free program through BlinkRx and in-office dispensing. Fifteen months post-launch, Qlosi refill rates reached 49%, approximately double those of dry eye therapies at retail pharmacies.Business Wire BlogBlinkRx Announces Availability of RYALTRIS® for Convenient Home Delivery Following Glenmark’s Commercial TransitionBlinkRx announced that RYALTRIS nasal spray is now available for fulfillment through its digital platform, following Glenmark Pharmaceuticals' transition to direct commercialization. The fixed-dose combination nasal spray treats seasonal allergic rhinitis in patients 12 years and older, with free home delivery. Patients can transfer existing prescriptions to BlinkRx.CbreCBRE Arranges Lease Expansion for Blink Health at Robinson Ridge in PittsburghCBRE has arranged a 37,816-square-foot lease expansion for Blink Health at Robinson Ridge in Pittsburgh, increasing the company's total footprint to 90,892 square feet. This expansion supports Blink Health's growth by adding more than 150 new jobs, bringing its local workforce to over 500 employees. The transaction involved CBRE representing both the tenant and the ownership entity, The Soffer Organization.FortuneSome health care CEOs are praising TrumpRx for empowering consumers to compare drug pricesThe Trump administration launched TrumpRx.gov, a direct-to-consumer platform offering 43 brand-name prescription drugs with varying levels of discounts to help consumers compare drug prices. Health care CEOs are responding, with GoodRx CEO Wendy Barnes praising it as expanding reach and aligning with their mission, though analysts note most listed prices exceed what insured Americans pay. The platform features 31 Pfizer drugs and raises questions about sustainability and its ties to vendor BlinkRx, where Donald Trump Jr. sits on the board.PharmiWeb.comBlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior AdvisorsBlinkRx, a digital health company focused on prescription medication access, has appointed former U.S. Senator Joe Manchin and healthcare executive Heather Manchin as Senior Advisors through their strategic advisory firm Manchin Partners. Senator Manchin brings bipartisan policy experience while Heather Manchin adds operational expertise from her tenure as former CEO of pharmaceutical company Mylan. The advisors will provide strategic counsel to BlinkRx's leadership as the company works to expand its prescription journey management platform and reduce medication costs.MorningstarBlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior AdvisorsBlinkRx, a digital health company focused on prescription medication access, announced the appointment of former U.S. Senator Joe Manchin and healthcare executive Heather Manchin as Senior Advisors. The pair, operating through their strategic advisory firm Manchin Partners, bring bipartisan policy experience and pharmaceutical industry leadership to support BlinkRx's expansion and modernization of the prescription drug ecosystem. The appointments are expected to provide strategic counsel as BlinkRx scales its platform to reduce costs, increase access, and simplify medication delivery.Business Wire BlogBlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior AdvisorsBlinkRx, a digital health company, announced the appointment of former U.S. Senator Joe Manchin and healthcare executive Heather Manchin as Senior Advisors through their strategic advisory firm Manchin Partners. Both advisors bring decades of experience spanning public policy and private-sector healthcare leadership, with Heather Manchin having previously served as CEO of pharmaceutical company Mylan. The appointments are intended to support BlinkRx's expansion of its prescription journey management platform as it works to reduce medication costs and increase access.DrugdiscoverytrendsTrump Jr.’s BlinkRx board seat draws Senate scrutiny as investigators probe pharma-linked telehealth prescribingA Senate investigation has found unusually high prescribing rates at pharmaceutical-linked telehealth partners—ranging from 100% at some platforms such as UpScript (714 out of 842 patients) and Cove (15 out of 15 patients)—while scrutinizing Donald Trump Jr.'s board seat at BlinkRx, a digital pharmacy company that helps drugmakers establish direct-to-consumer channels now funneled through the federal TrumpRx.gov portal. The senators' report detailed financial relationships between drugmakers like Eli Lilly and Pfizer and telehealth companies charging between $510,000 and $2.45 million per contract, along with data-sharing arrangements providing companies up to 28 patient data fields. The investigation raises concerns that patients may bypass insurance and face higher out-of-pocket costs while potentially receiving prescriptions through what lawmakers called 'virtual pill mills,' including drugs with serious safety risks like Pfizer's Xeljanz, which carries a black box warning.BioSpaceSCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan PotassiumScienture Holdings, Inc. and BlinkRx LLC announced a strategic collaboration to expand national access to Arbli™, the first FDA-approved ready-to-use oral suspension formulation of losartan potassium, expected to launch on the BlinkRx platform in Q1 2026. The U.S. losartan market generates approximately $245 million in annual sales across more than 71 million prescriptions. The partnership aims to improve patient therapy initiation rates by 52% and medication adherence by 40% through BlinkRx's automated patient access and delivery platform.